Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline versus placebo after laparoscopy for IVF outcomes in endometriosis
IRCT20091012002576N35Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in endometriosis and infertility comparing Cabergoline plus dienogest with Placebo plus dienogest (2 arms). Primary endpoints: Chemical pregnancy and Clinical pregnancy. Started Jan 2024; status: completed.
02
Drugs
cabergolinedienogest
03
Conditions
endometriosisinfertility
Beyond the preview
Go deeper on IRCT20091012002576N35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N35.